Lactobacillus rhamnosus GG Orchestrates an Antitumor Immune Response

BACKGROUND & AIMS: In colorectal cancer, approximately 95% of patients are refractory to immunotherapy because of low antitumor immune responses. Therefore, there is an exigent need to develop treatments that increase antitumor immune responses and decrease tumor burden to enhance immunotherapy....

Descripción completa

Detalles Bibliográficos
Autores principales: Owens, Joshua A., Saeedi, Bejan J., Naudin, Crystal R., Hunter-Chang, Sarah, Barbian, Maria E., Eboka, Richard U., Askew, Lauren, Darby, Trevor M., Robinson, Brian S., Jones, Rheinallt M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463873/
https://www.ncbi.nlm.nih.gov/pubmed/34111601
http://dx.doi.org/10.1016/j.jcmgh.2021.06.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8463873/
https://www.ncbi.nlm.nih.gov/pubmed/34111601
http://dx.doi.org/10.1016/j.jcmgh.2021.06.001

Ejemplares similares